Treatment Resistant Schizophrenia
Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment
8
Role of aripiprazole in treatment-resistant schizophrenia
10
Studies on the Association between Genetic Polymorphisms and Clozapine Drug Response in Treatment Resistant Schizophrenia.
258
Is treatment resistant schizophrenia categorically distinct from treatment responsive schizophrenia? a systematic review
14
Treatment resistant schizophrenia: a comprehensive survey of randomised controlled trials
8
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
13
Experiences, attitudes, and perceptions of caregivers of individuals with treatment resistant schizophrenia: a qualitative study
13
Influence of <em>5-HT1A</em> and <em>5-HTTLPR</em> genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia
7
Pharmacotherapy for treatment-resistant schizophrenia
15
<p>Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists</p>
13
Demographic Profile and Management Strategies of Treatment Resistant Schizophrenia and Treatment Resistant Depression in a Tertiary Care Referral Hospital
126
First episode psychosis in treatment resistant schizophrenia: a cross sectional study of a long term follow up cohort
10
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment resistant schizophrenia
9
Early Treatment Response in First Episode Psychosis: A 7-Tesla Magnetic Resonance Spectroscopic Study of Glutathione and Glutamate
115
Schizophrenia: the issue of informed consent to treatment with clozapine
7
Current treatment of multidrug resistant tuberculosis in Ethiopia: an aggregated and individual patients’ data analysis for outcome and effectiveness of the current regimens
10
Lack of tolerable treatment options for patients with schizophrenia
10
Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia
13
Atypical antipsychotics in the treatment of early-onset schizophrenia
7
Dermatoglyphic patterns as predictors of treatment response in Schizophrenia.
75